Member Exclusive News

The week in industry: first and only transdermal patch formulation for schizophrenia approved

This week: Partnership to identify novel ALS and FTD treatments, US$56 million to accelerate rare diseases program and DNA-encoded library-based drug discovery collaboration announced.

Please sign in or register for FREE

No comments yet.